Nathan Sadler

Array ( [id] => 2893990 [patent_doc_number] => 05240909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-08-31 [patent_title] => 'Use of lactoferrin for treatment of toxic effects of endotoxins' [patent_app_type] => 1 [patent_app_number] => 7/834327 [patent_app_country] => US [patent_app_date] => 1992-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7957 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/240/05240909.pdf [firstpage_image] =>[orig_patent_app_number] => 834327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2983361 [patent_doc_number] => 05250514 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-05 [patent_title] => 'Method of treating infertility or sub-fertility in adult men, and the use of preparations in the method' [patent_app_type] => 1 [patent_app_number] => 7/807861 [patent_app_country] => US [patent_app_date] => 1992-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1759 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/250/05250514.pdf [firstpage_image] =>[orig_patent_app_number] => 807861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2930233 [patent_doc_number] => 05246699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-21 [patent_title] => 'Maturation of hemopoietic cells' [patent_app_type] => 1 [patent_app_number] => 7/781248 [patent_app_country] => US [patent_app_date] => 1991-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14112 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/246/05246699.pdf [firstpage_image] =>[orig_patent_app_number] => 781248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2905768 [patent_doc_number] => 05215969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-01 [patent_title] => 'Dopaminergic neurotrophic factor for treatment of Parkinson\'s disease' [patent_app_type] => 1 [patent_app_number] => 7/804340 [patent_app_country] => US [patent_app_date] => 1991-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6572 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/215/05215969.pdf [firstpage_image] =>[orig_patent_app_number] => 804340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2979120 [patent_doc_number] => 05250296 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-10-05 [patent_title] => 'Immunostimulant agent containing interleukin-2 and 5\'-deoxy-5-fluorouridine' [patent_app_type] => 1 [patent_app_number] => 7/800366 [patent_app_country] => US [patent_app_date] => 1991-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6027 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/250/05250296.pdf [firstpage_image] =>[orig_patent_app_number] => 800366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3050573 [patent_doc_number] => 05306709 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-26 [patent_title] => 'Suppression of megakaryocytopoiesis by macrophage inflammatory proteins' [patent_app_type] => 1 [patent_app_number] => 7/792988 [patent_app_country] => US [patent_app_date] => 1991-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3418 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/306/05306709.pdf [firstpage_image] =>[orig_patent_app_number] => 792988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2936835 [patent_doc_number] => 05260308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-09 [patent_title] => 'Method to increase permeability of the blood-nerve/brain barriers to proteins' [patent_app_type] => 1 [patent_app_number] => 7/788497 [patent_app_country] => US [patent_app_date] => 1991-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5362 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/260/05260308.pdf [firstpage_image] =>[orig_patent_app_number] => 788497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2954029 [patent_doc_number] => 05231081 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-07-27 [patent_title] => 'Use of hemocyanins and arylphorins to influence the immune system and for the treatment of tumors' [patent_app_type] => 1 [patent_app_number] => 7/780386 [patent_app_country] => US [patent_app_date] => 1991-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4493 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/231/05231081.pdf [firstpage_image] =>[orig_patent_app_number] => 780386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2899665 [patent_doc_number] => 05217951 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-08 [patent_title] => 'Treatment of inflammation' [patent_app_type] => 1 [patent_app_number] => 7/781003 [patent_app_country] => US [patent_app_date] => 1991-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2609 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/217/05217951.pdf [firstpage_image] =>[orig_patent_app_number] => 781003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2928493 [patent_doc_number] => 05196191 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-03-23 [patent_title] => 'Temporal gamma-interferon administration for allergies' [patent_app_type] => 1 [patent_app_number] => 7/774429 [patent_app_country] => US [patent_app_date] => 1991-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 3449 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/196/05196191.pdf [firstpage_image] =>[orig_patent_app_number] => 774429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2900971 [patent_doc_number] => 05248499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-09-28 [patent_title] => 'Control of microbial infections in transplant patients' [patent_app_type] => 1 [patent_app_number] => 7/773382 [patent_app_country] => US [patent_app_date] => 1991-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7926 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/248/05248499.pdf [firstpage_image] =>[orig_patent_app_number] => 773382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3008249 [patent_doc_number] => 05276014 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-01-04 [patent_title] => 'Treatment of human lactation failure' [patent_app_type] => 1 [patent_app_number] => 7/765171 [patent_app_country] => US [patent_app_date] => 1991-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3078 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/276/05276014.pdf [firstpage_image] =>[orig_patent_app_number] => 765171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2905664 [patent_doc_number] => 05215965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-06-01 [patent_title] => 'Treatment of inflammation' [patent_app_type] => 1 [patent_app_number] => 7/755300 [patent_app_country] => US [patent_app_date] => 1991-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2126 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/215/05215965.pdf [firstpage_image] =>[orig_patent_app_number] => 755300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2921623 [patent_doc_number] => 05200393 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-06 [patent_title] => 'Lipid excipient for nasal delivery and topical application' [patent_app_type] => 1 [patent_app_number] => 7/758276 [patent_app_country] => US [patent_app_date] => 1991-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4552 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/200/05200393.pdf [firstpage_image] =>[orig_patent_app_number] => 758276 [rel_patent_id] =>[rel_patent_doc_number] =>)